Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

QDEL vs EHTH: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EHTH Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 5–4 Matrix Metrics)

EHTH Overall Winner 6-Pillar Tally: QDEL 2 – 4 EHTH Matrix Metrics: QDEL 4 – 5 EHTH

As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over QuidelOrtho Corporation (QDEL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). QDEL carries a Unified Composite Score of 44.2/100 (HOLD) at $9.96 (7.8x Forward P/E, 0.2% operating margin), whereas EHTH carries 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin).

  • Composite vs. Pillar Nuance: While QDEL currently prints a higher short-term Unified Composite Score (44.2/100 HOLD vs. EHTH 40.8/100 SELL), EHTH captures the overall institutional head-to-head verdict (5–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 0.2% operating margin) and revenue trajectory (-60.5% vs. -11.6% YoY).
  • Technical & Structure Timing Caution: QDEL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.1); meanwhile EHTH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About QDEL vs EHTH
QDEL NASDAQ
QuidelOrtho Corporation Common Stock
In Vitro & In Vivo Diagnostic Substances
$9.96
-2.45% 1D
Market Cap $736.9M
TTM Revenue $2.59B
Forward P/E 7.8x
Beta / 30D Vol 2.72β · 106% Vol
Unified Composite Score
44.2 / 100 HOLD
Tech 40.0 Fund 54.0 Flow 57.0 Mom 46.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 36
RSI-14: 36.1 · SMA20: $12.64 · SMA50: $12.17
EHTH NASDAQ Head-to-Head Winner
eHealth, Inc.
Insurance Agents, Brokers & Service
$0.35
-9.36% 1D
Market Cap $13.4M
TTM Revenue $469M
Forward P/E 0.2x
Beta / 30D Vol 1.61β · 117% Vol
Unified Composite Score
40.8 / 100 SELL
Tech 25.0 Fund 44.0 Flow 50.0 Mom 63.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -28.4%), weak momentum, RSI 25
RSI-14: 24.9 · SMA20: $0.50 · SMA50: $0.65

6-Pillar Scorecard Institutional Category Breakdown (QDEL 2 – 4 EHTH)

Columns: Metric · QDEL · EHTH
1. Valuation Multiples EHTH
Forward P/E 7.8x 0.2x
Trailing P/E 9.6x 0.2x
PEG Ratio 2.06x 0.72x
EV / Revenue 1.4x N/M
2. Growth & Scale QDEL
Revenue Growth (YoY) -11.6% -60.5%
Earnings Growth (YoY) -77.1% -17.6%
TTM Revenue (USD) $2.59B $469M
Market Cap $736.9M $13.4M
3. Profitability & Quality EHTH
Gross Margin 44.5% 100.0%
Operating Margin 0.2% 11.9%
Net Profit Margin -14.2% 4.9%
Return on Equity (ROE) -19.3% 2.6%
4. Balance Sheet & Cash Flow EHTH
Cash Generation (TTM) -$118M $58M EBITDA
Cash Flow Margin -4.5% 12.4% EBITDA Mgn
Net Cash / Leverage $2.95B Net Debt (1.74x D/E) $15.36 Book/Sh · 2.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning EHTH
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 101.3% (23rd %ile) 128.7% (56th %ile)
Put/Call OI Skew 2.41x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat QDEL
OpEx & R&D Intensity 44.3% of Rev ($1.15B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: QDEL (4) vs EHTH (5)
Institutional Metric QDEL EHTH Criterion Row Edge
Market Capitalization
Scale
$736.9M $13.4M Larger Scale QDEL
Trailing P/E Ratio
Valuation
9.6x 0.2x Lower Multiple EHTH
Forward P/E Ratio
Valuation
7.8x 0.2x Lower Multiple EHTH
Revenue Growth (YoY)
Growth
-11.6% -60.5% Higher Growth QDEL
Operating Margin (TTM)
Profitability
0.2% 11.9% Higher Margin EHTH
Net Profit Margin
Profitability
-14.2% 4.9% Higher Margin EHTH
Return on Equity (ROE)
Capital Efficiency
-19.3% 2.6% Higher ROE EHTH
52-Week Range Position
Momentum
0% ($10–$36) 0% ($0–$5) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
2.72β · 106% Vol 1.61β · 117% Vol Lower Realized Risk QDEL
Unified Institutional Score
Composite Signal
44.2 / 100 (HOLD) 40.8 / 100 (SELL) Higher Composite QDEL
Trailing 12M Revenue (USD)
Operating Scale
$2.59B $469M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.5% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.06x PEG · 1.4x EV/Rev 0.72x PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$118M ($2.95B Net Debt (1.74x D/E)) $58M EBITDA ($15.36 Book/Sh · 2.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon QDEL +16.69 pp
QDEL: -21.94% · EHTH: -38.63%
3M Horizon QDEL +44.2 pp
QDEL: -27.83% · EHTH: -72.03%
6M Horizon QDEL +67.82 pp
QDEL: -12.48% · EHTH: -80.3%
1Y Horizon QDEL +37.59 pp
QDEL: -53.33% · EHTH: -90.92%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QDEL vs EHTH. Trailing 12-month operating profitability (QDEL 0.2% vs EHTH 11.9%) and valuation multiples (QDEL 7.8x vs EHTH 0.2x Forward P/E) are benchmarked directly in Pillar 4 below.

QDEL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.59B
Gross Margin44.5%
Op. Margin0.2%
ROE / Fwd P/E-19.3% · 7.8x
EHTH ADR TTM Benchmark FX-Normalized USD
TTM Revenue$469M
Gross Margin100.0%
Op. Margin11.9%
ROE / Fwd P/E2.6% · 0.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
QDEL BREAKDOWN
91d in phase · OBV DISTRIBUTION
Current IV 101.3%
IV Percentile 23rd %ile
Put/Call OI Skew 2.41x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact QDEL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EHTH UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 128.7%
IV Percentile 56th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EHTH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
QDEL Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $736.9M market capitalization and 0.2% operating margin.
OpEx & R&D Reinvestment 44.3% of Rev ($1.15B)
90D Engineering Disclosures 0 Published
EHTH Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $13.4M market capitalization and 11.9% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ QDEL vs EHTH Key Questions & Quantitative Answers

As of Nov 17, 2026, eHealth, Inc. (EHTH) is the stronger overall head-to-head candidate over QuidelOrtho Corporation (QDEL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). QDEL carries a Unified Composite Score of 44.2/100 (HOLD) at $9.96 (7.8x Forward P/E, 0.2% operating margin), whereas EHTH carries 40.8/100 (SELL) at $0.35 (0.2x Forward P/E, 11.9% operating margin). Composite vs. Pillar Nuance: While QDEL currently prints a higher short-term Unified Composite Score (44.2/100 HOLD vs. EHTH 40.8/100 SELL), EHTH captures the overall institutional head-to-head verdict (5–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 0.2% operating margin) and revenue trajectory (-60.5% vs. -11.6% YoY). Technical & Structure Timing Caution: QDEL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.1); meanwhile EHTH is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

QDEL leads the Growth & Scale pillar: QDEL posts -11.6% YoY revenue growth and -77.1% YoY earnings growth on $2.59B TTM revenue (44.5% gross margin, 0.2% operating margin), compared with EHTH at -60.5% YoY revenue growth and -17.6% YoY earnings growth on $469M TTM revenue (100.0% gross margin, 11.9% operating margin). On trailing 12-month operating scale, QDEL generates $2.59B in USD-normalized revenue versus $469M for EHTH. In operating R&D and SG&A reinvestment, QDEL deploys 44.3% of Rev ($1.15B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for EHTH.

EHTH screens cheaper on headline valuation multiples. QDEL trades at 7.8x Forward P/E, 9.6x Trailing P/E, 2.06x PEG, and 1.4x EV/Revenue (-4.5% FCF margin), whereas EHTH trades at 0.2x Forward P/E, 0.2x Trailing P/E, 0.72x PEG, and N/M EV/Revenue (12.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against QDEL (-19.3% ROE) versus EHTH (2.6% ROE) capital efficiency.

In options market volatility and institutional positioning, QDEL carries 101.3% implied volatility (23rd %ile, Compressed (<25th %ile)), a 2.41x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.72β · 106% Vol realized risk). By comparison, EHTH carries 128.7% implied volatility (56th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 117% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.